# Celcuity Inc.: filings

CELC · Nasdaq · CIK 1603454 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/celc.md) · [Financials](/companies/celc/financials.md) · [Filings](/companies/celc/filings.md) · [Insiders](/companies/celc/insiders.md)

## Reports and events: 154 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 173, 8-K 89, 10-Q 27, SC 13G/A 26, D/A 21, 144 18, 424B5 15, 3 12, CORRESP 12, DEF 14A 11, SCHEDULE 13G/A 11, DEFA14A 10, S-8 10, SC 13G 10, 10-K 9, D 9, UPLOAD 8, EFFECT 7, S-3 6, SCHEDULE 13D/A 5, ARS 4, PRE 14A 4, SCHEDULE 13G 4, 8-K/A 3, FWP 3, S-1/A 3, 10-Q/A 2, 305B2 2, 424B3 2, 4/A 2, DRS/A 2, DRSLTR 2, S-3/A 2, 10-K/A 1, 424B4 1, 8-A12B 1, CERTNAS 1, DRS 1, S-1 1, S-1MEF 1, S-3ASR 1, SC 13D 1, SC 13D/A 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-02 | 12:05 ET | [8-K](/filings/0001193125-26-411297.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-411297 |
| 2026-09-30 | 12:05 ET | [8-K](/filings/0001193125-26-408353.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-408353 |
| 2026-08-26 | 12:35 ET | [8-K](/filings/0001193125-26-365975.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-365975 |
| 2026-08-13 | 21:15 ET | [10-Q](/filings/0001193125-26-349608.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349608 |
| 2026-08-13 | 20:15 ET | [8-K](/filings/0001193125-26-349227.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349227 |
| 2026-07-16 | 21:51 ET | [SCHEDULE 13D/A](/filings/0001104659-26-084327.md) | Ownership report, active investor, amended | 0001104659-26-084327 |
| 2026-07-15 | 20:05 ET | [8-K/A](/filings/0001493152-26-033357.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-033357 |
| 2026-07-15 | 21:39 ET | [8-K](/filings/0001493152-26-033223.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-033223 |
| 2026-06-08 | 20:10 ET | [8-K](/filings/0001493152-26-027717.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-027717 |
| 2026-06-02 | 12:10 ET | [8-K](/filings/0001493152-26-026761.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-026761 |
| 2026-05-20 | 11:30 ET | [8-K/A](/filings/0001493152-26-024510.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-024510 |
| 2026-05-18 | 20:05 ET | [8-K](/filings/0001493152-26-024175.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-024175 |
| 2026-05-14 | 21:15 ET | [10-Q](/filings/0001493152-26-023180.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023180 |
| 2026-05-14 | 20:05 ET | [8-K](/filings/0001493152-26-023065.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-023065 |
| 2026-05-01 | 21:10 ET | [8-K](/filings/0001493152-26-020918.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-020918 |
| 2026-04-02 | 20:30 ET | [DEF 14A](/filings/0001493152-26-014937.md) | Proxy statement, period 2026-04-02 | 0001493152-26-014937 |
| 2026-03-26 | 11:30 ET | [10-K](/filings/0001493152-26-012801.md) | Annual report, period 2025-12-31 | 0001493152-26-012801 |
| 2026-03-25 | 20:10 ET | [8-K](/filings/0001493152-26-012668.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-012668 |
| 2026-03-24 | 20:06 ET | [SCHEDULE 13D/A](/filings/0001104659-26-033844.md) | Ownership report, active investor, amended | 0001104659-26-033844 |
| 2026-03-09 | 23:17 ET | [SCHEDULE 13D/A](/filings/0001072613-26-000251.md) | Ownership report, active investor, amended | 0001072613-26-000251 |
| 2026-02-12 | 21:30 ET | [8-K](/filings/0001493152-26-006444.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-006444 |
| 2026-01-16 | 22:30 ET | [SCHEDULE 13D/A](/filings/0001072613-26-000056.md) | Ownership report, active investor, amended | 0001072613-26-000056 |
| 2025-11-17 | 21:36 ET | [8-K](/filings/0001493152-25-023897.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-023897 |
| 2025-11-13 | 22:15 ET | [10-Q](/filings/0001493152-25-022401.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022401 |
| 2025-11-12 | 21:06 ET | [8-K](/filings/0001493152-25-021903.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021903 |
| 2025-10-20 | 10:30 ET | [8-K](/filings/0001493152-25-018565.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-018565 |
| 2025-09-10 | 11:58 ET | [8-K](/filings/0001641172-25-027025.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-027025 |
| 2025-08-18 | 22:02 ET | [SCHEDULE 13D/A](/filings/0001072613-25-000648.md) | Ownership report, active investor, amended | 0001072613-25-000648 |
| 2025-08-14 | 21:01 ET | [10-Q](/filings/0001641172-25-024148.md) | Quarterly report, period 2025-06-30 | 0001641172-25-024148 |
| 2025-08-14 | 20:07 ET | [8-K](/filings/0001641172-25-024007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-024007 |
| 2025-08-01 | 21:41 ET | [SCHEDULE 13D](/filings/0001104659-25-073189.md) | Ownership report, active investor | 0001104659-25-073189 |
| 2025-08-01 | 20:05 ET | [8-K](/filings/0001641172-25-021894.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021894 |
| 2025-07-31 | 20:15 ET | [8-K](/filings/0001641172-25-021739.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021739 |
| 2025-07-29 | 12:52 ET | [8-K](/filings/0001641172-25-021274.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021274 |
| 2025-07-28 | 11:21 ET | [8-K](/filings/0001641172-25-021095.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021095 |
| 2025-06-30 | 11:10 ET | [8-K](/filings/0001641172-25-017043.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-017043 |
| 2025-05-16 | 21:00 ET | [8-K](/filings/0001641172-25-011273.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-011273 |
| 2025-05-15 | 21:00 ET | [10-Q](/filings/0001641172-25-011053.md) | Quarterly report, period 2025-03-31 | 0001641172-25-011053 |
| 2025-05-14 | 20:34 ET | [8-K](/filings/0001641172-25-010308.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010308 |
| 2025-04-01 | 21:00 ET | [DEF 14A](/filings/0001641172-25-002114.md) | Proxy statement, period 2025-04-01 | 0001641172-25-002114 |
| 2025-03-31 | 21:00 ET | [10-K](/filings/0001641172-25-001826.md) | Annual report, period 2024-12-31 | 0001641172-25-001826 |
| 2025-03-31 | 20:05 ET | [8-K](/filings/0001641172-25-001698.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-001698 |
| 2024-12-06 | 21:30 ET | [8-K](/filings/0001493152-24-049089.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-049089 |
| 2024-11-14 | 22:00 ET | [10-Q](/filings/0001493152-24-046022.md) | Quarterly report, period 2024-09-30 | 0001493152-24-046022 |
| 2024-11-14 | 21:05 ET | [8-K](/filings/0001493152-24-045804.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045804 |
| 2024-10-09 | 20:05 ET | [8-K](/filings/0001493152-24-040594.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-040594 |
| 2024-08-28 | 20:05 ET | [DEF 14A](/filings/0001493152-24-034185.md) | Proxy statement, period 2024-08-28 | 0001493152-24-034185 |
| 2024-08-14 | 21:06 ET | [10-Q](/filings/0001493152-24-032372.md) | Quarterly report, period 2024-06-30 | 0001493152-24-032372 |
| 2024-08-14 | 20:10 ET | [8-K](/filings/0001493152-24-032197.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-032197 |
| 2024-05-31 | 21:00 ET | [8-K](/filings/0001493152-24-022227.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-022227 |

Page 1 of 4. [Older](/companies/celc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.